Table 1. Baseline Characteristics.
| Group S2 | Group S1 | Group SN | Group N | |
|---|---|---|---|---|
| Number (person) | 30 | 30 | 30 | 30 |
| Sex (M/F) | 17/13 | 16/14 | 17/13 | 8/22 |
| Age (yr) | 44.7 ± 15.2 | 52.5 ± 15.3 | 45.1 ± 13.7 | 46.9 ± 12.2 |
| Weight (kg) | 61.2 ± 10.3 | 67.9 ± 11.3 | 63.0 ± 11.1 | 60.6 ± 8.9 |
| Height (cm) | 164.0 ± 7.6 | 164.6 ± 9.1 | 163.4 ± 9.0 | 162.1 ± 6.6 |
| ASA (I/II) | 18/12 | 17/13 | 21/9 | 19/11 |
| Type of Operation | ||||
| Face or neck surgery | 18 | 13 | 15 | 17 |
| Laparoscopic surgery | 5 | 6 | 6 | 4 |
| Laparotomy surgery | 5 | 6 | 7 | 6 |
| Surgery of extremities | 2 | 5 | 2 | 3 |
Values are expressed as number or mean ± standard deviation. Group S2: sugammadex 2 mg/kg, Group S1: sugammadex 1 mg/kg, Group SN: sugammadex 1 mg/kg + neostigmine 50 µg/kg + glycopyrrolate 10 µg/kg, Group N: neostigmine 50 µg/kg + glycopyrrolate 10 µg/kg. ASA: American Society of Anesthesiologists physical status.